| Literature DB >> 24768959 |
Marisa R Adelman1, Mark W Dassel2, Howard T Sharp2.
Abstract
Essure hysteroscopic sterilization has been US Food and Drug Administration-approved in the United States since 2002. Complications associated with the Essure device include improper placement (malpositioning), unintended pregnancy, pain, infection, and nickel allergy. The rarity of complications, compounded by underreporting, makes it difficult to determine best practices insofar as management. This systematic review synthesizes the national and global experience with management of Essure-related complications and suggests treatment options when data allow.Entities:
Keywords: Chronic pain; Complication; Essure; Hysteroscopic sterilization; Malposition
Mesh:
Substances:
Year: 2014 PMID: 24768959 DOI: 10.1016/j.jmig.2014.03.019
Source DB: PubMed Journal: J Minim Invasive Gynecol ISSN: 1553-4650 Impact factor: 4.137